世界の院内感染症検査市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Hospital Acquired Disease Testing Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A12346 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、81ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、院内感染症検査のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。院内感染症検査の種類別市場規模（機器・試薬、消耗品）、用途別市場規模（疾病検査、薬剤耐性検査）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・院内感染症検査の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Life technologies、Diatherix laboratories、Qiagen GmbH、Meridian Biosciences、Nordion、Roche、Cantel Medical Corporation、Cepheid ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：機器・試薬、消耗品 ・用途別分析2016年-2026年：疾病検査、薬剤耐性検査 ・院内感染症検査の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・院内感染症検査のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・院内感染症検査のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・院内感染症検査の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・院内感染症検査の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Hospital Acquired Disease Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Hospital Acquired Disease Testing size is estimated to be USD 704.1 million in 2026 from USD 466.3 million in 2020, with a change XX% between 2020 and 2021. The global Hospital Acquired Disease Testing market size is expected to grow at a CAGR of 10.9% for the next five years.

Market segmentation
Hospital Acquired Disease Testing market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Instrument and Reagents
Consumables

Market segment by Application, can be divided into
Disease Testing
Drug-Resistance Testing

Market segment by players, this report covers
Life technologies
Diatherix laboratories
Qiagen GmbH
Meridian Biosciences
Nordion
Roche
Cantel Medical Corporation
Cepheid

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Hospital Acquired Disease Testing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Hospital Acquired Disease Testing, with revenue, gross margin and global market share of Hospital Acquired Disease Testing from 2019 to 2021.
Chapter 3, the Hospital Acquired Disease Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Hospital Acquired Disease Testing market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Hospital Acquired Disease Testing research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Hospital Acquired Disease Testing
1.2 Classification of Hospital Acquired Disease Testing by Type
1.2.1 Overview: Global Hospital Acquired Disease Testing Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Hospital Acquired Disease Testing Revenue Market Share by Type in 2020
1.2.3 Instrument and Reagents
1.2.4 Consumables
1.3 Global Hospital Acquired Disease Testing Market by Application
1.3.1 Overview: Global Hospital Acquired Disease Testing Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Disease Testing
1.3.3 Drug-Resistance Testing
1.4 Global Hospital Acquired Disease Testing Market Size & Forecast
1.5 Global Hospital Acquired Disease Testing Market Size and Forecast by Region
1.5.1 Global Hospital Acquired Disease Testing Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Hospital Acquired Disease Testing Market Size by Region, (2016-2021)
1.5.3 North America Hospital Acquired Disease Testing Market Size and Prospect (2016-2026)
1.5.4 Europe Hospital Acquired Disease Testing Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Hospital Acquired Disease Testing Market Size and Prospect (2016-2026)
1.5.6 South America Hospital Acquired Disease Testing Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Hospital Acquired Disease Testing Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Hospital Acquired Disease Testing Market Drivers
1.6.2 Hospital Acquired Disease Testing Market Restraints
1.6.3 Hospital Acquired Disease Testing Trends Analysis
2 Company Profiles
2.1 Life technologies
2.1.1 Life technologies Details
2.1.2 Life technologies Major Business
2.1.3 Life technologies Hospital Acquired Disease Testing Product and Solutions
2.1.4 Life technologies Hospital Acquired Disease Testing Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Life technologies Recent Developments and Future Plans
2.2 Diatherix laboratories
2.2.1 Diatherix laboratories Details
2.2.2 Diatherix laboratories Major Business
2.2.3 Diatherix laboratories Hospital Acquired Disease Testing Product and Solutions
2.2.4 Diatherix laboratories Hospital Acquired Disease Testing Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Diatherix laboratories Recent Developments and Future Plans
2.3 Qiagen GmbH
2.3.1 Qiagen GmbH Details
2.3.2 Qiagen GmbH Major Business
2.3.3 Qiagen GmbH Hospital Acquired Disease Testing Product and Solutions
2.3.4 Qiagen GmbH Hospital Acquired Disease Testing Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Qiagen GmbH Recent Developments and Future Plans
2.4 Meridian Biosciences
2.4.1 Meridian Biosciences Details
2.4.2 Meridian Biosciences Major Business
2.4.3 Meridian Biosciences Hospital Acquired Disease Testing Product and Solutions
2.4.4 Meridian Biosciences Hospital Acquired Disease Testing Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Meridian Biosciences Recent Developments and Future Plans
2.5 Nordion
2.5.1 Nordion Details
2.5.2 Nordion Major Business
2.5.3 Nordion Hospital Acquired Disease Testing Product and Solutions
2.5.4 Nordion Hospital Acquired Disease Testing Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Nordion Recent Developments and Future Plans
2.6 Roche
2.6.1 Roche Details
2.6.2 Roche Major Business
2.6.3 Roche Hospital Acquired Disease Testing Product and Solutions
2.6.4 Roche Hospital Acquired Disease Testing Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Roche Recent Developments and Future Plans
2.7 Cantel Medical Corporation
2.7.1 Cantel Medical Corporation Details
2.7.2 Cantel Medical Corporation Major Business
2.7.3 Cantel Medical Corporation Hospital Acquired Disease Testing Product and Solutions
2.7.4 Cantel Medical Corporation Hospital Acquired Disease Testing Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Cantel Medical Corporation Recent Developments and Future Plans
2.8 Cepheid
2.8.1 Cepheid Details
2.8.2 Cepheid Major Business
2.8.3 Cepheid Hospital Acquired Disease Testing Product and Solutions
2.8.4 Cepheid Hospital Acquired Disease Testing Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Cepheid Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Hospital Acquired Disease Testing Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Hospital Acquired Disease Testing Players Market Share
3.2.2 Top 10 Hospital Acquired Disease Testing Players Market Share
3.2.3 Market Competition Trend
3.3 Hospital Acquired Disease Testing Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Hospital Acquired Disease Testing Revenue and Market Share by Type (2016-2021)
4.2 Global Hospital Acquired Disease Testing Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Hospital Acquired Disease Testing Revenue Market Share by Application (2016-2021)
5.2 Hospital Acquired Disease Testing Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Hospital Acquired Disease Testing Revenue by Type (2016-2026)
6.2 North America Hospital Acquired Disease Testing Revenue by Application (2016-2026)
6.3 North America Hospital Acquired Disease Testing Market Size by Country
6.3.1 North America Hospital Acquired Disease Testing Revenue by Country (2016-2026)
6.3.2 United States Hospital Acquired Disease Testing Market Size and Forecast (2016-2026)
6.3.3 Canada Hospital Acquired Disease Testing Market Size and Forecast (2016-2026)
6.3.4 Mexico Hospital Acquired Disease Testing Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Hospital Acquired Disease Testing Revenue by Type (2016-2026)
7.2 Europe Hospital Acquired Disease Testing Revenue by Application (2016-2026)
7.3 Europe Hospital Acquired Disease Testing Market Size by Country
7.3.1 Europe Hospital Acquired Disease Testing Revenue by Country (2016-2026)
7.3.2 Germany Hospital Acquired Disease Testing Market Size and Forecast (2016-2026)
7.3.3 France Hospital Acquired Disease Testing Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Hospital Acquired Disease Testing Market Size and Forecast (2016-2026)
7.3.5 Russia Hospital Acquired Disease Testing Market Size and Forecast (2016-2026)
7.3.6 Italy Hospital Acquired Disease Testing Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Hospital Acquired Disease Testing Revenue by Type (2016-2026)
8.2 Asia-Pacific Hospital Acquired Disease Testing Revenue by Application (2016-2026)
8.3 Asia-Pacific Hospital Acquired Disease Testing Market Size by Region
8.3.1 Asia-Pacific Hospital Acquired Disease Testing Revenue by Region (2016-2026)
8.3.2 China Hospital Acquired Disease Testing Market Size and Forecast (2016-2026)
8.3.3 Japan Hospital Acquired Disease Testing Market Size and Forecast (2016-2026)
8.3.4 South Korea Hospital Acquired Disease Testing Market Size and Forecast (2016-2026)
8.3.5 India Hospital Acquired Disease Testing Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Hospital Acquired Disease Testing Market Size and Forecast (2016-2026)
8.3.7 Australia Hospital Acquired Disease Testing Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Hospital Acquired Disease Testing Revenue by Type (2016-2026)
9.2 South America Hospital Acquired Disease Testing Revenue by Application (2016-2026)
9.3 South America Hospital Acquired Disease Testing Market Size by Country
9.3.1 South America Hospital Acquired Disease Testing Revenue by Country (2016-2026)
9.3.2 Brazil Hospital Acquired Disease Testing Market Size and Forecast (2016-2026)
9.3.3 Argentina Hospital Acquired Disease Testing Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Hospital Acquired Disease Testing Revenue by Type (2016-2026)
10.2 Middle East & Africa Hospital Acquired Disease Testing Revenue by Application (2016-2026)
10.3 Middle East & Africa Hospital Acquired Disease Testing Market Size by Country
10.3.1 Middle East & Africa Hospital Acquired Disease Testing Revenue by Country (2016-2026)
10.3.2 Turkey Hospital Acquired Disease Testing Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Hospital Acquired Disease Testing Market Size and Forecast (2016-2026)
10.3.4 UAE Hospital Acquired Disease Testing Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Hospital Acquired Disease Testing Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Hospital Acquired Disease Testing Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Hospital Acquired Disease Testing Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Hospital Acquired Disease Testing Revenue (USD Million) by Region (2016-2021)
Table 5. Global Hospital Acquired Disease Testing Revenue Market Share by Region (2021-2026)
Table 6. Life technologies Corporate Information, Head Office, and Major Competitors
Table 7. Life technologies Major Business
Table 8. Life technologies Hospital Acquired Disease Testing Product and Solutions
Table 9. Life technologies Hospital Acquired Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Diatherix laboratories Corporate Information, Head Office, and Major Competitors
Table 11. Diatherix laboratories Major Business
Table 12. Diatherix laboratories Hospital Acquired Disease Testing Product and Solutions
Table 13. Diatherix laboratories Hospital Acquired Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Qiagen GmbH Corporate Information, Head Office, and Major Competitors
Table 15. Qiagen GmbH Major Business
Table 16. Qiagen GmbH Hospital Acquired Disease Testing Product and Solutions
Table 17. Qiagen GmbH Hospital Acquired Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Meridian Biosciences Corporate Information, Head Office, and Major Competitors
Table 19. Meridian Biosciences Major Business
Table 20. Meridian Biosciences Hospital Acquired Disease Testing Product and Solutions
Table 21. Meridian Biosciences Hospital Acquired Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Nordion Corporate Information, Head Office, and Major Competitors
Table 23. Nordion Major Business
Table 24. Nordion Hospital Acquired Disease Testing Product and Solutions
Table 25. Nordion Hospital Acquired Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Roche Corporate Information, Head Office, and Major Competitors
Table 27. Roche Major Business
Table 28. Roche Hospital Acquired Disease Testing Product and Solutions
Table 29. Roche Hospital Acquired Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Cantel Medical Corporation Corporate Information, Head Office, and Major Competitors
Table 31. Cantel Medical Corporation Major Business
Table 32. Cantel Medical Corporation Hospital Acquired Disease Testing Product and Solutions
Table 33. Cantel Medical Corporation Hospital Acquired Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Cepheid Corporate Information, Head Office, and Major Competitors
Table 35. Cepheid Major Business
Table 36. Cepheid Hospital Acquired Disease Testing Product and Solutions
Table 37. Cepheid Hospital Acquired Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Global Hospital Acquired Disease Testing Revenue (USD Million) by Players (2019-2021)
Table 39. Global Hospital Acquired Disease Testing Revenue Share by Players (2019-2021)
Table 40. Breakdown of Hospital Acquired Disease Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 41. Hospital Acquired Disease Testing Players Head Office, Products and Services Provided
Table 42. Hospital Acquired Disease Testing Mergers & Acquisitions in the Past Five Years
Table 43. Hospital Acquired Disease Testing New Entrants and Expansion Plans
Table 44. Global Hospital Acquired Disease Testing Revenue (USD Million) by Type (2016-2021)
Table 45. Global Hospital Acquired Disease Testing Revenue Share by Type (2016-2021)
Table 46. Global Hospital Acquired Disease Testing Revenue Forecast by Type (2021-2026)
Table 47. Global Hospital Acquired Disease Testing Revenue by Application (2016-2021)
Table 48. Global Hospital Acquired Disease Testing Revenue Forecast by Application (2021-2026)
Table 49. North America Hospital Acquired Disease Testing Revenue by Type (2016-2021) & (USD Million)
Table 50. North America Hospital Acquired Disease Testing Revenue by Type (2021-2026) & (USD Million)
Table 51. North America Hospital Acquired Disease Testing Revenue by Application (2016-2021) & (USD Million)
Table 52. North America Hospital Acquired Disease Testing Revenue by Application (2021-2026) & (USD Million)
Table 53. North America Hospital Acquired Disease Testing Revenue by Country (2016-2021) & (USD Million)
Table 54. North America Hospital Acquired Disease Testing Revenue by Country (2021-2026) & (USD Million)
Table 55. Europe Hospital Acquired Disease Testing Revenue by Type (2016-2021) & (USD Million)
Table 56. Europe Hospital Acquired Disease Testing Revenue by Type (2021-2026) & (USD Million)
Table 57. Europe Hospital Acquired Disease Testing Revenue by Application (2016-2021) & (USD Million)
Table 58. Europe Hospital Acquired Disease Testing Revenue by Application (2021-2026) & (USD Million)
Table 59. Europe Hospital Acquired Disease Testing Revenue by Country (2016-2021) & (USD Million)
Table 60. Europe Hospital Acquired Disease Testing Revenue by Country (2021-2026) & (USD Million)
Table 61. Asia-Pacific Hospital Acquired Disease Testing Revenue by Type (2016-2021) & (USD Million)
Table 62. Asia-Pacific Hospital Acquired Disease Testing Revenue by Type (2021-2026) & (USD Million)
Table 63. Asia-Pacific Hospital Acquired Disease Testing Revenue by Application (2016-2021) & (USD Million)
Table 64. Asia-Pacific Hospital Acquired Disease Testing Revenue by Application (2021-2026) & (USD Million)
Table 65. Asia-Pacific Hospital Acquired Disease Testing Revenue by Region (2016-2021) & (USD Million)
Table 66. Asia-Pacific Hospital Acquired Disease Testing Revenue by Region (2021-2026) & (USD Million)
Table 67. South America Hospital Acquired Disease Testing Revenue by Type (2016-2021) & (USD Million)
Table 68. South America Hospital Acquired Disease Testing Revenue by Type (2021-2026) & (USD Million)
Table 69. South America Hospital Acquired Disease Testing Revenue by Application (2016-2021) & (USD Million)
Table 70. South America Hospital Acquired Disease Testing Revenue by Application (2021-2026) & (USD Million)
Table 71. South America Hospital Acquired Disease Testing Revenue by Country (2016-2021) & (USD Million)
Table 72. South America Hospital Acquired Disease Testing Revenue by Country (2021-2026) & (USD Million)
Table 73. Middle East & Africa Hospital Acquired Disease Testing Revenue by Type (2016-2021) & (USD Million)
Table 74. Middle East & Africa Hospital Acquired Disease Testing Revenue by Type (2021-2026) & (USD Million)
Table 75. Middle East & Africa Hospital Acquired Disease Testing Revenue by Application (2016-2021) & (USD Million)
Table 76. Middle East & Africa Hospital Acquired Disease Testing Revenue by Application (2021-2026) & (USD Million)
Table 77. Middle East & Africa Hospital Acquired Disease Testing Revenue by Country (2016-2021) & (USD Million)
Table 78. Middle East & Africa Hospital Acquired Disease Testing Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Hospital Acquired Disease Testing Picture
Figure 2. Global Hospital Acquired Disease Testing Revenue Market Share by Type in 2020
Figure 3. Instrument and Reagents
Figure 4. Consumables
Figure 5. Hospital Acquired Disease Testing Revenue Market Share by Application in 2020
Figure 6. Disease Testing Picture
Figure 7. Drug-Resistance Testing Picture
Figure 8. Global Hospital Acquired Disease Testing Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 9. Global Hospital Acquired Disease Testing Revenue and Forecast (2016-2026) & (USD Million)
Figure 10. Global Hospital Acquired Disease Testing Revenue Market Share by Region (2016-2026)
Figure 11. Global Hospital Acquired Disease Testing Revenue Market Share by Region in 2020
Figure 12. North America Hospital Acquired Disease Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 13. Europe Hospital Acquired Disease Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Asia-Pacific Hospital Acquired Disease Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. South America Hospital Acquired Disease Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Middle East and Africa Hospital Acquired Disease Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Hospital Acquired Disease Testing Market Drivers
Figure 18. Hospital Acquired Disease Testing Market Restraints
Figure 19. Hospital Acquired Disease Testing Market Trends
Figure 20. Life technologies Recent Developments and Future Plans
Figure 21. Diatherix laboratories Recent Developments and Future Plans
Figure 22. Qiagen GmbH Recent Developments and Future Plans
Figure 23. Meridian Biosciences Recent Developments and Future Plans
Figure 24. Nordion Recent Developments and Future Plans
Figure 25. Roche Recent Developments and Future Plans
Figure 26. Cantel Medical Corporation Recent Developments and Future Plans
Figure 27. Cepheid Recent Developments and Future Plans
Figure 28. Global Hospital Acquired Disease Testing Revenue Share by Players in 2020
Figure 29. Hospital Acquired Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 30. Global Top 3 Players Hospital Acquired Disease Testing Revenue Market Share in 2020
Figure 31. Global Top 10 Players Hospital Acquired Disease Testing Revenue Market Share in 2020
Figure 32. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 33. Global Hospital Acquired Disease Testing Revenue Share by Type in 2020
Figure 34. Global Hospital Acquired Disease Testing Market Share Forecast by Type (2021-2026)
Figure 35. Global Hospital Acquired Disease Testing Revenue Share by Application in 2020
Figure 36. Global Hospital Acquired Disease Testing Market Share Forecast by Application (2021-2026)
Figure 37. North America Hospital Acquired Disease Testing Sales Market Share by Type (2016-2026)
Figure 38. North America Hospital Acquired Disease Testing Sales Market Share by Application (2016-2026)
Figure 39. North America Hospital Acquired Disease Testing Revenue Market Share by Country (2016-2026)
Figure 40. United States Hospital Acquired Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Hospital Acquired Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Hospital Acquired Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Hospital Acquired Disease Testing Sales Market Share by Type (2016-2026)
Figure 44. Europe Hospital Acquired Disease Testing Sales Market Share by Application (2016-2026)
Figure 45. Europe Hospital Acquired Disease Testing Revenue Market Share by Country (2016-2026)
Figure 46. Germany Hospital Acquired Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France Hospital Acquired Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom Hospital Acquired Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia Hospital Acquired Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy Hospital Acquired Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Hospital Acquired Disease Testing Sales Market Share by Type (2016-2026)
Figure 52. Asia-Pacific Hospital Acquired Disease Testing Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific Hospital Acquired Disease Testing Revenue Market Share by Region (2016-2026)
Figure 54. China Hospital Acquired Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Japan Hospital Acquired Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. South Korea Hospital Acquired Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. India Hospital Acquired Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Southeast Asia Hospital Acquired Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Australia Hospital Acquired Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South America Hospital Acquired Disease Testing Sales Market Share by Type (2016-2026)
Figure 61. South America Hospital Acquired Disease Testing Sales Market Share by Application (2016-2026)
Figure 62. South America Hospital Acquired Disease Testing Revenue Market Share by Country (2016-2026)
Figure 63. Brazil Hospital Acquired Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Argentina Hospital Acquired Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Middle East and Africa Hospital Acquired Disease Testing Sales Market Share by Type (2016-2026)
Figure 66. Middle East and Africa Hospital Acquired Disease Testing Sales Market Share by Application (2016-2026)
Figure 67. Middle East and Africa Hospital Acquired Disease Testing Revenue Market Share by Country (2016-2026)
Figure 68. Turkey Hospital Acquired Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Saudi Arabia Hospital Acquired Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. UAE Hospital Acquired Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Methodology
Figure 72. Research Process and Data Source

---